2025-08-19 |
13G/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
164,424,420 |
66,000,000 |
|
|
|
2025-08-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
7,598,797 |
4,200,000 |
|
|
|
2025-08-05 |
13G
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
3,418,068 |
6,728,116 |
|
|
|
2025-07-28 |
13D/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
7,803,202 |
8,714,522 |
|
|
|
2025-07-24 |
13G
|
HLVX / HilleVax, Inc.
|
|
|
2,892,000 |
|
|
|
2025-06-27 |
13D
|
ZYME / Zymeworks Inc.
|
|
17,699,774 |
22,970,388 |
|
|
|
2025-05-29 |
13D/A
|
PRTA / Prothena Corporation plc
|
|
5,304,596 |
0 |
|
|
|
2025-05-19 |
13D/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
7,094,049 |
7,803,202 |
|
|
|
2025-05-16 |
13D
|
ITOS / iTeos Therapeutics, Inc.
|
|
5,730,000 |
10,688,978 |
|
|
|
2025-05-15 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
3,182,444 |
0 |
|
|
|
2025-05-15 |
13G/A
|
TECX / Tectonic Therapeutic, Inc.
|
|
849,143 |
935,121 |
|
|
|
2025-05-15 |
13G/A
|
TCRX / TScan Therapeutics, Inc.
|
|
5,000,000 |
662,833 |
|
|
|
2025-05-15 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
11,578,447 |
0 |
|
|
|
2025-05-15 |
13G/A
|
KLRS / Kalaris Therapeutics, Inc.
|
|
|
201,718 |
|
|
|
2025-05-15 |
13G/A
|
IMNM / Immunome, Inc.
|
|
3,879,415 |
4,079,415 |
|
|
|
2025-05-15 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
6,800,493 |
0 |
|
|
|
2025-05-15 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
356,117 |
210,634 |
|
|
|
2025-05-13 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
2,656,640 |
5,730,000 |
|
|
|
2025-05-08 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
1,608,616 |
2,656,640 |
|
|
|
2025-05-06 |
13D/A
|
PRTA / Prothena Corporation plc
|
|
11,584,280 |
5,304,596 |
|
|
|
2025-04-08 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
16,858,418 |
17,699,774 |
|
|
|
2025-03-17 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
15,720,161 |
16,858,418 |
|
|
|
2025-02-18 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
|
15,720,161 |
|
|
|
2025-02-14 |
13G/A
|
ALVR / AlloVir, Inc.
|
|
10,655,366 |
408,688 |
|
|
|
2025-02-14 |
13G/A
|
ETON / Eton Pharmaceuticals, Inc.
|
|
1,397,669 |
1,981,003 |
|
|
|
2025-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
5,441,896 |
3,341,653 |
|
|
|
2025-02-14 |
13G/A
|
TNGX / Tango Therapeutics, Inc.
|
|
13,330,736 |
10,630,736 |
|
|
|
2025-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
571,727 |
388,861 |
|
|
|
2025-02-14 |
13G/A
|
WHWK / Whitehawk Therapeutics, Inc.
|
|
1,845,253 |
345,253 |
|
|
|
2025-01-13 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
|
15,411,078 |
|
|
|
2025-01-03 |
13D/A
|
PRTA / Prothena Corporation plc
|
|
11,584,280 |
11,584,280 |
|
|
|
2024-12-23 |
13G/A
|
MRSN / Mersana Therapeutics, Inc.
|
|
19,364,688 |
11,578,447 |
|
|
|
2024-12-23 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
14,132,291 |
14,692,281 |
|
|
|
2024-12-17 |
13G
|
QURE / uniQure N.V.
|
|
|
3,632,087 |
|
|
|
2024-12-09 |
13G
|
ETON / Eton Pharmaceuticals, Inc.
|
|
|
1,397,669 |
|
|
|
2024-11-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
6,995,861 |
5,441,896 |
|
|
|
2024-11-14 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
3,493,194 |
1,250,385 |
|
|
|
2024-11-14 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
7,264,147 |
356,117 |
|
|
|
2024-11-14 |
13G/A
|
XNCR / Xencor, Inc.
|
|
5,282,516 |
6,719,304 |
|
|
|
2024-11-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
3,851,507 |
5,617,719 |
|
|
|
2024-11-14 |
13G/A
|
ATRA / Atara Biotherapeutics, Inc.
|
|
10,067,043 |
493,463 |
|
|
|
2024-11-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
5,717,324 |
571,727 |
|
|
|
2024-11-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
1,944,672 |
1,608,616 |
|
|
|
2024-11-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,117,400 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
6,275,210 |
3,418,068 |
|
|
|
2024-11-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
4,155,375 |
4,288,120 |
|
|
|
2024-11-14 |
13G/A
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
5,618,779 |
3,223,851 |
|
|
|
2024-10-08 |
13D/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
6,505,890 |
7,094,049 |
|
|
|
2024-09-03 |
13G
|
WHWK / Whitehawk Therapeutics, Inc.
|
|
|
1,845,253 |
|
|
|
2024-08-23 |
13D
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
6,505,890 |
6,505,890 |
|
|
|
2024-08-16 |
13D/A
|
ANAB / AnaptysBio, Inc.
|
|
7,520,424 |
7,794,996 |
|
|
|
2024-07-01 |
13G
|
TECX / Tectonic Therapeutic, Inc.
|
|
|
849,143 |
|
|
|
2024-05-31 |
13G
|
HOOK / HOOKIPA Pharma Inc.
|
|
4,595,024 |
5,717,324 |
|
|
|
2024-05-03 |
13G
|
MORF / Morphic Holding, Inc.
|
|
211,262 |
3,014,752 |
|
|
|
2024-04-08 |
13G/A
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
1,219,774 |
|
|
|
2024-03-26 |
13G/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
113,424,420 |
164,424,420 |
|
|
|
2024-03-11 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
4,155,375 |
|
|
|
2024-02-22 |
13D
|
ZYME / Zymeworks Inc.
|
|
14,132,291 |
14,132,291 |
|
|
|
2024-02-16 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
1,944,672 |
|
|
|
2024-02-14 |
13G/A
|
MORF / Morphic Holding, Inc.
|
|
3,951,566 |
211,262 |
|
|
|
2024-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
6,184,861 |
6,995,861 |
|
|
|
2024-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
6,184,861 |
6,995,861 |
|
|
|
2024-02-14 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
6,184,861 |
6,995,861 |
|
|
|
2024-02-14 |
13G/A
|
MORF / Morphic Holding, Inc.
|
|
3,951,566 |
211,262 |
|
|
|
2024-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
13,437,473 |
14,132,291 |
|
|
|
2024-02-14 |
13G/A
|
XNCR / Xencor, Inc.
|
|
5,282,516 |
5,282,516 |
|
|
|
2024-02-14 |
13G/A
|
TPST / Tempest Therapeutics, Inc.
|
|
1,052,810 |
0 |
|
|
|
2024-02-14 |
13G/A
|
THRD / Third Harmonic Bio, Inc.
|
|
2,982,444 |
3,182,444 |
|
|
|
2024-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
3,460,208 |
0 |
|
|
|
2024-02-14 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
7,198,700 |
132,579 |
|
|
|
2024-02-14 |
13G/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
3,418,068 |
6,275,210 |
|
|
|
2024-02-14 |
13G/A
|
NGM / NGM Biopharmaceuticals, Inc.
|
|
6,435,518 |
2,385,873 |
|
|
|
2024-02-14 |
13G
|
NGNE / Neurogene Inc.
|
|
|
1,282,168 |
|
|
|
2024-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
6,638,371 |
7,598,797 |
|
|
|
2024-02-14 |
13G/A
|
JANX / Janux Therapeutics, Inc.
|
|
3,255,270 |
0 |
|
|
|
2024-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
4,973,489 |
4,595,024 |
|
|
|
2024-02-14 |
13G/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
6,505,890 |
6,505,890 |
|
|
|
2024-02-14 |
13G/A
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
5,232,279 |
5,618,779 |
|
|
|
2024-02-14 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
3,123,300 |
6,800,493 |
|
|
|
2024-02-14 |
13G/A
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
6,307,547 |
11,173,068 |
|
|
|
2024-02-14 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
3,948,360 |
7,264,147 |
|
|
|
2024-02-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
887,076 |
|
|
|
2024-02-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
3,560,700 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
1,785,663 |
1,086,956 |
|
|
|
2024-02-01 |
13G
|
ALVR / AlloVir, Inc.
|
|
|
10,655,366 |
|
|
|
2024-01-30 |
13G
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
113,424,420 |
|
|
|
2023-12-27 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
5,748,399 |
7,396,979 |
|
|
|
2023-11-21 |
13G
|
ATRA / Atara Biotherapeutics, Inc.
|
|
|
10,067,043 |
|
|
|
2023-10-16 |
13G/A
|
TNGX / Tango Therapeutics, Inc.
|
|
7,827,636 |
13,330,736 |
|
|
|
2023-10-12 |
13G
|
IMNM / Immunome, Inc.
|
|
|
3,879,415 |
|
|
|
2023-10-02 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
5,748,399 |
|
|
|
2023-09-21 |
13G
|
TNGX / Tango Therapeutics, Inc.
|
|
|
7,827,636 |
|
|
|
2023-09-13 |
13G
|
THRD / Third Harmonic Bio, Inc.
|
|
|
2,982,444 |
|
|
|
2023-07-27 |
13G
|
MRSN / Mersana Therapeutics, Inc.
|
|
|
19,364,688 |
|
|
|
2023-07-18 |
13G
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
6,307,547 |
|
|
|
2023-06-21 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
7,568,573 |
13,437,473 |
|
|
|
2023-06-16 |
13G/A
|
RVMD / Revolution Medicines, Inc.
|
|
4,478,050 |
7,198,700 |
|
|
|
2023-06-07 |
13G
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
4,442,352 |
6,505,890 |
|
|
|
2023-06-05 |
13G
|
TCRX / TScan Therapeutics, Inc.
|
|
|
5,000,000 |
|
|
|
2023-02-14 |
13G/A
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
3,407,246 |
4,442,352 |
|
|
|
2023-02-14 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
2,759,505 |
0 |
|
|
|
2023-02-14 |
13G/A
|
TSVT / 2seventy bio, Inc.
|
|
|
1,143,494 |
|
|
|
2023-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
5,090,856 |
4,973,489 |
|
|
|
2023-02-14 |
13G
|
TPST / Tempest Therapeutics, Inc.
|
|
0 |
1,052,810 |
|
|
|
2023-02-13 |
13G/A
|
SURF / Surface Oncology Inc
|
|
4,653,000 |
3,924,713 |
|
|
|
2023-02-13 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
3,123,300 |
3,123,300 |
|
|
|
2023-02-13 |
13G/A
|
XNCR / Xencor, Inc.
|
|
4,906,106 |
5,282,516 |
|
|
|
2023-02-13 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
3,213,300 |
3,948,360 |
|
|
|
2023-02-10 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
6,082,200 |
6,117,400 |
|
|
|
2023-02-10 |
13G/A
|
AKUS / Akouos Inc
|
|
1,975,984 |
0 |
|
|
|
2023-02-10 |
13G/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
3,468,944 |
3,418,068 |
|
|
|
2023-02-10 |
13G/A
|
GRTSQ / Gritstone bio, Inc.
|
|
6,319,232 |
0 |
|
|
|
2023-02-10 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
4,543,447 |
6,638,371 |
|
|
|
2023-02-10 |
13G/A
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
5,376,134 |
6,184,861 |
|
|
|
2023-02-10 |
13G/A
|
ALEC / Alector, Inc.
|
|
4,994,970 |
4,056,548 |
|
|
|
2023-02-10 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
5,523,358 |
0 |
|
|
|
2023-02-10 |
13G/A
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
1,975,611 |
0 |
|
|
|
2023-02-10 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
9,202,702 |
0 |
|
|
|
2023-01-23 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
4,278,069 |
4,478,050 |
|
|
|
2023-01-23 |
13G
|
JANX / Janux Therapeutics, Inc.
|
|
3,255,270 |
3,255,270 |
|
|
|
2023-01-13 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
4,276,507 |
3,851,507 |
|
|
|
2023-01-09 |
13G/A
|
GRPH / Graphite Bio, Inc.
|
|
5,712,096 |
8,538,446 |
|
|
|
2022-12-23 |
13G
|
ACET / Adicet Bio, Inc.
|
|
3,560,700 |
3,560,700 |
|
|
|
2022-11-23 |
13G
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
5,232,279 |
|
|
|
2022-11-18 |
13G
|
GRPH / Graphite Bio, Inc.
|
|
|
5,712,096 |
|
|
|
2022-11-14 |
13G
|
ABEO / Abeona Therapeutics Inc.
|
|
|
1,785,663 |
|
|
|
2022-11-01 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
5,968,573 |
7,568,573 |
|
|
|
2022-10-28 |
13G
|
NGM / NGM Biopharmaceuticals, Inc.
|
|
|
6,435,518 |
|
|
|
2022-10-28 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
5,968,573 |
|
|
|
2022-09-26 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
3,493,194 |
|
|
|
2022-09-16 |
13G
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
3,460,208 |
|
|
|
2022-06-27 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
|
4,278,069 |
|
|
|
2022-05-16 |
13G
|
ARVN / Arvinas, Inc.
|
|
|
3,123,300 |
|
|
|
2022-04-26 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
3,557,507 |
4,276,507 |
|
|
|
2022-04-11 |
13G
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
1,975,611 |
|
|
|
2022-04-08 |
13G
|
HOOK / HOOKIPA Pharma Inc.
|
|
5,090,856 |
5,090,856 |
|
|
|
2022-03-14 |
13G
|
SURF / Surface Oncology Inc
|
|
48,558 |
4,653,000 |
|
|
|
2022-02-14 |
13G
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
3,213,300 |
|
|
|
2022-02-14 |
13G/A
|
RCUS / Arcus Biosciences, Inc.
|
|
4,572,047 |
5,523,358 |
|
|
|
2022-02-14 |
13G/A
|
VYGR / Voyager Therapeutics, Inc.
|
|
3,557,507 |
3,557,507 |
|
|
|
2022-02-14 |
13G/A
|
TSVT / 2seventy bio, Inc.
|
|
|
1,917,063 |
|
|
|
2022-02-14 |
13G/A
|
ALEC / Alector, Inc.
|
|
4,742,634 |
4,994,970 |
|
|
|
2022-02-14 |
13G/A
|
STTK / Shattuck Labs, Inc.
|
|
3,295,088 |
0 |
|
|
|
2022-02-14 |
13G/A
|
OVID / Ovid Therapeutics Inc.
|
|
|
6,082,200 |
|
|
|
2022-02-14 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
7,977,702 |
9,202,702 |
|
|
|
2022-02-14 |
13G/A
|
RNA / Avidity Biosciences, Inc.
|
|
2,103,950 |
2,759,505 |
|
|
|
2022-02-14 |
13G/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
3,092,218 |
3,468,944 |
|
|
|
2022-02-14 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
3,122,704 |
860,619 |
|
|
|
2022-02-14 |
13G/A
|
MORF / Morphic Holding, Inc.
|
|
2,839,884 |
3,951,566 |
|
|
|
2022-02-14 |
13G/A
|
BCEL / Atreca, Inc.
|
|
2,426,685 |
0 |
|
|
|
2022-02-14 |
13G/A
|
BCEL / Atreca, Inc.
|
|
2,426,685 |
0 |
|
|
|
2022-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
28,555,310 |
9,615,385 |
|
|
|
2022-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
3,650,080 |
2,538,970 |
|
|
|
2022-02-14 |
13G/A
|
SVRA / Savara Inc.
|
|
3,040,540 |
3,040,540 |
|
|
|
2022-02-14 |
13G/A
|
SBTX / Silverback Therapeutics Inc
|
|
2,533,635 |
1,060,010 |
|
|
|
2022-02-14 |
13G/A
|
GRTS / Gritstone bio, Inc.
|
|
4,934,932 |
6,319,232 |
|
|
|
2022-02-14 |
13G/A
|
ACIU / AC Immune SA
|
|
4,702,160 |
749,585 |
|
|
|
2022-02-14 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
4,368,500 |
0 |
|
|
|
2022-02-14 |
13G/A
|
XNCR / Xencor, Inc.
|
|
4,547,072 |
4,906,106 |
|
|
|
2022-02-03 |
13G
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
3,407,246 |
|
|
|
2022-01-31 |
13G
|
KURA / Kura Oncology, Inc.
|
|
1,773,037 |
4,543,447 |
|
|
|
2022-01-14 |
13D/A
|
PRTA / Prothena Corporation plc
|
|
9,426,640 |
11,584,280 |
|
|
|
2021-12-10 |
13G/A
|
ODT / Odonate Therapeutics Inc
|
|
5,701,669 |
0 |
|
|
|
2021-12-10 |
13G
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
|
5,376,134 |
|
|
|
2021-11-18 |
13G/A
|
ODT / Odonate Therapeutics Inc
|
|
3,363,700 |
5,701,669 |
|
|
|
2021-11-16 |
13G
|
TSVT / 2seventy bio, Inc.
|
|
|
1,890,663 |
|
|
|
2021-10-22 |
13G
|
VYGR / Voyager Therapeutics, Inc.
|
|
|
3,557,507 |
|
|
|
2021-10-05 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
5,081,077 |
81,077 |
|
|
|
2021-09-23 |
13G/A
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
3,579,377 |
5,081,077 |
|
|
|
2021-07-19 |
13G
|
ODT / Odonate Therapeutics Inc
|
|
|
3,363,700 |
|
|
|
2021-07-19 |
13G
|
RCUS / Arcus Biosciences, Inc.
|
|
|
4,572,047 |
|
|
|
2021-07-12 |
13G
|
ALEC / Alector, Inc.
|
|
|
4,742,634 |
|
|
|
2021-05-17 |
13G
|
STTK / Shattuck Labs, Inc.
|
|
|
3,295,088 |
|
|
|
2021-05-11 |
13D/A
|
ANAB / AnaptysBio, Inc.
|
|
7,151,624 |
7,520,424 |
|
|
|
2021-05-11 |
13G
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
3,579,377 |
|
|
|
2021-04-13 |
13D/A
|
ANAB / AnaptysBio, Inc.
|
|
7,151,624 |
7,151,624 |
|
|
|
2021-04-13 |
13D/A
|
ANAB / AnaptysBio, Inc.
|
|
7,151,624 |
7,151,624 |
|
|
|
2021-03-10 |
13D
|
ANAB / AnaptysBio, Inc.
|
|
3,813,324 |
7,151,624 |
|
|
|
2021-02-16 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
600,000 |
600,000 |
|
|
|
2021-02-16 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
5,275,000 |
7,977,702 |
|
|
|
2021-02-16 |
13G/A
|
SURF / Surface Oncology Inc
|
|
5,033,861 |
48,558 |
|
|
|
2021-02-16 |
13G
|
RNA / Avidity Biosciences, Inc.
|
|
|
2,103,950 |
|
|
|
2021-02-16 |
13G/A
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
2,642,218 |
3,092,218 |
|
|
|
2021-02-16 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
3,915,880 |
3,122,704 |
|
|
|
2021-02-16 |
13G/A
|
MORF / Morphic Holding, Inc.
|
|
2,154,845 |
2,839,884 |
|
|
|
2021-02-16 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
4,241,953 |
1,773,037 |
|
|
|
2021-02-16 |
13G/A
|
GERN / Geron Corporation
|
|
28,846,154 |
28,555,310 |
|
|
|
2021-02-16 |
13G/A
|
BCEL / Atreca, Inc.
|
|
1,481,411 |
2,426,685 |
|
|
|
2021-02-16 |
13G
|
AKUS / Akouos Inc
|
|
|
1,975,984 |
|
|
|
2021-02-16 |
13G/A
|
SVRA / Savara Inc.
|
|
3,040,540 |
3,040,540 |
|
|
|
2021-02-16 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,015,400 |
600,000 |
|
|
|
2021-02-12 |
13G/A
|
SVRA / Savara Inc.
|
|
4,473,204 |
3,040,540 |
|
|
|
2021-02-12 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
3,043,827 |
0 |
|
|
|
2021-02-12 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,627,597 |
0 |
|
|
|
2021-02-12 |
13G/A
|
STRO / Sutro Biopharma, Inc.
|
|
2,328,492 |
93,416 |
|
|
|
2021-02-12 |
13G/A
|
SELB / Selecta Biosciences Inc
|
|
6,896,551 |
2,298,850 |
|
|
|
2021-02-12 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
2,322,644 |
3,650,080 |
|
|
|
2021-02-12 |
13G/A
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
2,248,306 |
0 |
|
|
|
2021-02-12 |
13G/A
|
PBYI / Puma Biotechnology, Inc.
|
|
2,536,156 |
0 |
|
|
|
2021-02-12 |
13G/A
|
MRUS / Merus N.V.
|
|
1,906,861 |
0 |
|
|
|
2021-02-12 |
13G/A
|
GLYC / GlycoMimetics, Inc.
|
|
2,909,800 |
0 |
|
|
|
2021-02-12 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
2,087,312 |
1,509,812 |
|
|
|
2021-01-26 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
4,368,500 |
|
|
|
2021-01-22 |
13G
|
ACIU / AC Immune SA
|
|
|
4,702,160 |
|
|
|
2021-01-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,966,100 |
3,813,324 |
|
|
|
2021-01-04 |
13G
|
SBTX / Silverback Therapeutics Inc
|
|
|
2,533,635 |
|
|
|
2021-01-04 |
13G
|
GRTS / Gritstone bio, Inc.
|
|
|
4,934,932 |
|
|
|
2020-11-02 |
13G
|
SLDB / Solid Biosciences Inc.
|
|
0 |
5,275,000 |
|
|
|
2020-08-28 |
13G
|
STRO / Sutro Biopharma, Inc.
|
|
|
2,328,492 |
|
|
|
2020-07-20 |
13G
|
GLYC / GlycoMimetics, Inc.
|
|
|
2,909,800 |
|
|
|
2020-06-17 |
13G
|
XNCR / Xencor, Inc.
|
|
|
4,547,072 |
|
|
|
2020-05-29 |
13G
|
GERN / Geron Corporation
|
|
|
28,846,154 |
|
|
|
2020-05-29 |
13G
|
SURF / Surface Oncology Inc
|
|
1,301,713 |
5,033,861 |
|
|
|
2020-05-01 |
13G
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
2,642,218 |
|
|
|
2020-04-24 |
13G/A
|
MRUS / Merus N.V.
|
|
1,718,200 |
1,906,861 |
|
|
|
2020-03-26 |
13G
|
PBYI / Puma Biotechnology, Inc.
|
|
|
2,536,156 |
|
|
|
2020-02-14 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
3,281,502 |
0 |
|
|
|
2020-02-14 |
13G/A
|
CRIS / Curis, Inc.
|
|
2,982,208 |
0 |
|
|
|
2020-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
3,141,323 |
0 |
|
|
|
2020-02-14 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
1,060,018 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
3,102,238 |
0 |
|
|
|
2020-02-14 |
13G/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
423,441 |
0 |
|
|
|
2020-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
1,474,228 |
0 |
|
|
|
2020-02-14 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
2,087,312 |
|
|
|
2020-02-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,720,500 |
1,966,100 |
|
|
|
2020-02-14 |
13G/A
|
BCEL / Atreca, Inc.
|
|
|
1,481,411 |
|
|
|
2020-02-14 |
13G/A
|
US16706W1027 / Chiasma Inc
|
|
3,043,827 |
3,043,827 |
|
|
|
2020-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
3,316,407 |
3,627,597 |
|
|
|
2020-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,595,643 |
449,338 |
|
|
|
2020-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
5,276,753 |
4,241,953 |
|
|
|
2020-02-14 |
13G
|
MRUS / Merus N.V.
|
|
|
1,718,200 |
|
|
|
2020-02-14 |
13G/A
|
MORF / Morphic Holding, Inc.
|
|
2,239,704 |
2,154,845 |
|
|
|
2020-02-14 |
13G/A
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
2,392,556 |
2,248,306 |
|
|
|
2020-02-14 |
13G/A
|
SURF / Surface Oncology Inc
|
|
2,261,328 |
1,301,713 |
|
|
|
2020-02-14 |
13G/A
|
XCUR / Exicure, Inc.
|
|
5,945,225 |
3,544,186 |
|
|
|
2020-02-14 |
13G/A
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
1,200,000 |
1,015,400 |
|
|
|
2020-01-06 |
13G
|
SELB / Selecta Biosciences Inc
|
|
|
6,896,551 |
|
|
|
2020-01-06 |
13G
|
SVRA / Savara Inc.
|
|
|
4,473,204 |
|
|
|
2020-01-03 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
0 |
2,322,644 |
|
|
|
2019-12-27 |
13G
|
CYCN / Cyclerion Therapeutics, Inc.
|
|
|
1,811,000 |
|
|
|
2019-12-27 |
13G
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
3,915,880 |
|
|
|
2019-12-23 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
502,500 |
2,388,268 |
|
|
|
2019-12-17 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
1,200,000 |
|
|
|
2019-12-13 |
13D
|
PRTA / Prothena Corporation plc
|
|
9,426,640 |
9,426,640 |
|
|
|
2019-11-18 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
1,720,500 |
|
|
|
2019-11-14 |
13G
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
5,070,424 |
|
|
|
2019-10-23 |
13G
|
IPHYF / Innate Pharma S.A.
|
|
|
6,623,114 |
|
|
|
2019-10-15 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
3,141,323 |
|
|
|
2019-10-07 |
13G
|
XCUR / Exicure, Inc.
|
|
|
5,945,225 |
|
|
|
2019-08-26 |
13D
|
PRTA / Prothena Corporation plc
|
|
|
9,426,640 |
|
|
|
2019-08-02 |
13G
|
SLDB / Solid Biosciences Inc.
|
|
|
3,102,238 |
|
|
|
2019-07-09 |
13G
|
MORF / Morphic Holding, Inc.
|
|
|
2,239,704 |
|
|
|
2019-06-28 |
13G
|
US74140Y1010 / Prevail Therapeutics Inc.
|
|
|
2,392,556 |
|
|
|
2019-06-28 |
13G
|
BCEL / Atreca, Inc.
|
|
|
1,486,979 |
|
|
|
2019-05-10 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
2,404,853 |
502,500 |
|
|
|
2019-04-08 |
13G
|
US16706W1027 / Chiasma Inc
|
|
|
3,043,827 |
|
|
|
2019-03-11 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
5,603,191 |
|
|
|
|
2019-02-14 |
13G/A
|
SRRK / Scholar Rock Holding Corporation
|
|
2,671,161 |
1,474,228 |
|
|
|
2019-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,107,600 |
679,746 |
|
|
|
2019-02-14 |
13G
|
ABUS / Arbutus Biopharma Corporation
|
|
|
3,281,502 |
|
|
|
2019-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
571,126 |
2,404,853 |
|
|
|
2019-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
3,766,852 |
5,276,753 |
|
|
|
2019-02-14 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
1,758,973 |
2,265,880 |
|
|
|
2019-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
4,836,547 |
3,316,407 |
|
|
|
2019-02-14 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
1,039,500 |
1,595,643 |
|
|
|
2019-02-14 |
13G/A
|
ONTX / Onconova Therapeutics, Inc.
|
|
7,564,359 |
423,441 |
|
|
|
2019-02-14 |
13G/A
|
SURF / Surface Oncology Inc
|
|
1,747,657 |
2,261,328 |
|
|
|
2019-02-14 |
13G/A
|
KZR / Kezar Life Sciences, Inc.
|
|
1,288,198 |
1,060,018 |
|
|
|
2019-01-10 |
13G/A
|
IMDZ / Immune Design Corp.
|
|
3,562,600 |
5,603,191 |
|
|
|
2018-12-27 |
13G
|
CRIS / Curis, Inc.
|
|
|
2,982,208 |
|
|
|
2018-12-27 |
13G
|
CURO / CURO Group Holdings Corp.
|
|
|
2,982,208 |
|
|
|
2018-11-13 |
13G
|
SURF / Surface Oncology Inc
|
|
|
1,747,657 |
|
|
|
2018-07-16 |
13G
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
1,758,973 |
|
|
|
2018-07-11 |
13G
|
KZR / Kezar Life Sciences, Inc.
|
|
|
1,288,198 |
|
|
|
2018-06-04 |
13G
|
SRRK / Scholar Rock Holding Corporation
|
|
|
2,671,161 |
|
|
|
2018-06-04 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
2,843,170 |
1,039,500 |
|
|
|
2018-05-22 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
4,625,519 |
707,547 |
|
|
|
2018-05-07 |
13G
|
ONTX / Onconova Therapeutics, Inc.
|
|
|
7,564,359 |
|
|
|
2018-02-14 |
13G/A
|
FATE / Fate Therapeutics, Inc.
|
|
2,537,026 |
0 |
|
|
|
2018-02-14 |
13G/A
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
3,622,271 |
0 |
|
|
|
2018-02-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
5,117,144 |
0 |
|
|
|
2018-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
|
0 |
|
|
|
2018-02-14 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
4,642,396 |
4,625,519 |
|
|
|
2018-02-14 |
13G
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
2,107,600 |
|
|
|
2018-02-14 |
13G/A
|
TPST / Tempest Therapeutics, Inc.
|
|
3,512,332 |
0 |
|
|
|
2018-01-03 |
13G
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
4,836,547 |
4,836,547 |
|
|
|
2018-01-02 |
13G
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
4,836,547 |
|
|
|
2017-11-06 |
13G
|
IMDZ / Immune Design Corp.
|
|
|
3,562,600 |
|
|
|
2017-09-07 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
1,961,335 |
4,642,396 |
|
|
|
2017-08-21 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,611,906 |
3,766,852 |
|
|
|
2017-08-08 |
13G
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
3,622,271 |
|
|
|
2017-05-30 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
5,117,144 |
|
|
|
2017-05-15 |
13G
|
FGEN / FibroGen, Inc.
|
|
|
1,322,991 |
|
|
|
2017-05-10 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
1,415,000 |
|
|
|
2017-03-31 |
13G
|
TPST / Tempest Therapeutics, Inc.
|
|
|
3,512,332 |
|
|
|
2017-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
2,098,302 |
571,126 |
|
|
|
2017-02-14 |
13G
|
FATE / Fate Therapeutics, Inc.
|
|
|
2,537,026 |
|
|
|
2017-02-14 |
13G/A
|
17K / Self Storage Group ASA
|
|
|
571,126 |
|
|
|
2017-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,450,000 |
2,611,906 |
|
|
|
2017-01-30 |
13G
|
LIFE / aTyr Pharma, Inc.
|
|
|
1,961,335 |
|
|
|
2016-02-12 |
13G/A
|
17K / Self Storage Group ASA
|
|
|
1,432,765 |
|
|
|
2016-02-12 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
1,877,069 |
2,098,302 |
|
|
|
2016-02-11 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
2,449,300 |
2,450,000 |
|
|
|
2016-02-11 |
13G/A
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
2,843,170 |
2,843,170 |
|
|
|
2016-01-15 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
0 |
|
|
|
2015-11-18 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
1,450,000 |
2,449,300 |
|
|
|
2015-10-09 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
1,887,069 |
1,877,069 |
|
|
|
2015-06-30 |
13G
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
2,843,170 |
|
|
|
2015-03-17 |
13G
|
KURA / Kura Oncology, Inc.
|
|
1,450,000 |
1,450,000 |
|
|
|
2015-03-16 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
1,450,000 |
|
|
|
2015-02-17 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
1,986,413 |
|
|
|
2015-02-17 |
13G/A
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
78,958 |
|
|
|
2015-02-17 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,009,752 |
|
|
|
2015-02-17 |
13G/A
|
17K / Self Storage Group ASA
|
|
|
1,344,431 |
|
|
|
2014-10-08 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
961,352 |
|
|
|
2014-08-29 |
13G
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
1,058,200 |
|
|
|
2014-02-21 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
1,840,000 |
|
|
|
2013-12-20 |
13G
|
17K / Self Storage Group ASA
|
|
|
923,187 |
|
|
|
2013-11-27 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
1,840,000 |
|
|
|
2013-09-18 |
13G
|
GNVC / GenVec, Inc.
|
|
|
1,295,000 |
|
|
|